Metabolic efficacy
Evaluate candidate activity in a diet-induced obesity setting using protocol-defined metabolic outcomes.
METABOLIC DISEASE MODEL
Diet-Induced Obesity (DIO) Models
High-fat diet-induced obesity models are available in mice and rats for metabolic-disease pharmacology and integrated exposure or biomarker-oriented studies.
The reviewed documentation identifies mouse and rat DIO platforms; strain, diet composition, induction period, and readouts are confirmed per project.
MODEL OVERVIEW
Diet-induced metabolic disease studies built around the development question.
DIO studies can be scoped around the compound, species, treatment schedule, and required metabolic, exposure, PK/PD, or biomarker outputs. The exact animal background and induction design are selected during technical review.
Therapeutic areaObesity, Metabolic disease
SpeciesMouse, Rat
Model formatHigh-fat diet induced
Typical useEfficacy, PK/PD, Biomarkers
TYPICAL APPLICATIONS
What this model can support.
Dose-response studies
Compare dose levels, schedules, routes, and treatment duration against predefined study objectives.
PK/PD integration
Link exposure and pharmacodynamic measurements to efficacy readouts when required.
Biomarker & tissue work
Collect protocol-defined samples for metabolic biomarkers and downstream tissue analysis.
COMMON READOUTS
Readouts selected around the study question.
Endpoints are finalized with the selected model, species or strain, treatment design, and partner laboratory before study placement.
Efficacy
Protocol-defined obesity and metabolic-disease outcomes selected for the study question.
Exposure
Plasma or selected tissue exposure when PK work is incorporated.
PK/PD
Exposure-response and pharmacodynamic measurements when required.
Biomarkers & tissues
Protocol-defined biomarker panels and tissue collection for downstream analysis.
The reviewed documentation identifies mouse and rat DIO models but does not disclose a single standardized strain. Final design is confirmed during technical review.
STUDY DESIGN
Key factors aligned before execution.
- Mouse or rat study platform
- Strain and diet composition
- Induction duration and study entry criteria
- Dose route, schedule, and formulation
- Metabolic and PK/PD endpoints
- Biomarker and tissue-collection plan
Discuss Your Program
Share the compound, mechanism, development question, preferred model, and intended endpoints. We can review fit, feasibility, and the appropriate partner-laboratory route for a DIO study.Required fields are marked with an asterisk(*).